Norman Schwartz
Chairman & CEO at Bio-Rad Laboratories. Based in Hercules, California.
- Rank
- 217th of 14,644
- Companies held
- 1
- Largest holding
- BIO, 100.0% of total
- Latest SEC filing
- Sep 6, 2026
- Listed but not counted
- $25.7M
What the $1.24B is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories BIO Bio-Rad A Common Stock | Through David Schwartz Exemption Trust | 1,781,356 | $367.50 | $655M | 52.7% | Form 4, Sep 4, 2026 |
| Bio-Rad Laboratories BIO Bio-Rad A Common Stock | Through David Schwartz Non-Exempt Martial Trust | 898,931 | $367.50 | $330M | 26.6% | Form 4, Sep 4, 2026 |
| Bio-Rad Laboratories BIO Bio-Rad A Common Stock | Directly | 449,019 | $367.50 | $165M | 13.3% | Form 4, Sep 6, 2026 |
| Bio-Rad Laboratories BIO Bio-Rad B Common Stock | Indirectly (see filing footnote) Reported jointly by 2 insiders; split evenly | 218,755 | $367.50 | $80.4M | 6.5% | Form 4, Sep 4, 2026 |
| Bio-Rad Laboratories BIO Bio-Rad A Common Stock | Through Alice N. Schwartz Revocable Trust | 34,311 | $367.50 | $12.6M | 1.0% | Form 4, Sep 4, 2026 |
| Bio-Rad Laboratories BIO Bio-Rad A Common Stock | Through David Schwartz Exempt Martial Trust | 90 | $367.50 | $33K | 0.0% | Form 4, Sep 4, 2026 |
Share counts are the amounts Norman Schwartz reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Norman Schwartz's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories BIO Bio-Rad B Common Stock | Through Charitable Remainder Unitrust Held for a foundation or charity | 57,000 | $367.50 | $20.9M | — | Form 4, Sep 4, 2026 |
| Bio-Rad Laboratories BIO Bio-Rad B Common Stock | Through Blue Raven Partners, L.P. Held by a company or fund the insider manages | 13,006 | $367.50 | $4.8M | — | Form 4, Sep 4, 2026 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 214 | Maurice J. Duca 10% owner, AppFolio. Santa Barbara, CA | $1.26B |
| 215 | Jeffrey W. Edwards President, CEO and Chairman, Installed Building Products. Columbus, OH | $1.25B |
| 216 | Michael Hsing CEO, Monolithic Power Systems. West Palm Beach, FL | $1.25B |
| 217 | Norman Schwartz Chairman & CEO, Bio-Rad Laboratories. Hercules, CA | $1.24B |
| 218 | Tony Xu CHIEF EXECUTIVE OFFICER, DoorDash. San Francisco, CA | $1.24B |
| 219 | Reed Hastings Director, Netflix. Los Gatos, CA | $1.24B |
| 220 | Bipul Sinha Chairman of the Board and CEO, Rubrik. Palo Alto, CA | $1.23B |
Other Bio-Rad Laboratories insiders
All BIO insiders- Alice N. Schwartz$101M10% owner. #1486 overall
- Steven Schwartz$14.6M10% owner. #6580 overall
- Colleen Corey$7.2MEVP, Global Human Resources. #11195 overall
- Roop K. Lakkaraju$1.5MEVP, Chief Financial Officer. #8299 overall
Questions
How much stock does Norman Schwartz own?
Norman Schwartz holds $1,243,054,785 in listed stock based on SEC filings and current prices, mostly Bio-Rad Laboratories (BIO). That ranks 217th on the Stock Rich List.
Is this Norman Schwartz's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.